Double-Negative T Cells Regulate Hepatic Stellate Cell Activation to Promote Liver Fibrosis Progression via NLRP3
AimWe mainly explored the role and mechanism of double-negative T cells (DNTs) in liver fibrosis.MethodsDNTs were co-cultured with mouse hepatic stellate cells (HSCs). Later, cell viability was detected by Cell Counting Kit-8 (CCK-8) assay; α-SMA expression was measured through fluorescence staining...
Main Authors: | Yi Yang, Yongjia Sheng, Jin Wang, Xiaohong Zhou, Wenyan Li, Caiqun Zhang, Li Guo, Chenyang Han |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-03-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2022.857116/full |
Similar Items
-
Corrigendum: Double-negative T cells regulate hepatic stellate cell activation to promote liver fibrosis progression via NLRP3
by: Yi Yang, et al.
Published: (2023-12-01) -
Mechanisms of NLRP3 inflammasome-mediated hepatic stellate cell activation: Therapeutic potential for liver fibrosis
by: Harsh Vardhan Charan, et al.
Published: (2023-03-01) -
RANKL inhibits activation of hepatic stellate cells during hepatic fibrosis in mice
by: ZHOU Lijia, et al.
Published: (2023-01-01) -
Progress of researches on inducing hepatic stellate cell ferroptosis for treatment of liver fibrosis
by: SUN Lijie, HAO Dandan
Published: (2024-01-01) -
Mechanical homeostasis imbalance in hepatic stellate cells activation and hepatic fibrosis
by: Yuan-Quan Zhao, et al.
Published: (2023-04-01)